Phase 1 safety outcomes of mesenchymal stromal stem cell therapy in pateints with low and intermediate-1 ipss risk myelodysplastic syndrome
Keyword(s):
Phase 1
◽
Keyword(s):
2014 ◽
Vol 189
(3)
◽
pp. 364-365
◽
Keyword(s):
2019 ◽
Vol 25
(2)
◽
pp. 149-163
◽
Keyword(s):
Keyword(s):
2019 ◽
Vol 109
◽
pp. 1196-1205
◽
2014 ◽
Vol 189
(3)
◽
pp. 363-364
◽
Keyword(s):
Keyword(s):